Publication Name	World Journal of Meta-Analysis
Manuscript ID	57210
Country	United States

Received	2020-06-01 14:37
Peer-Review Started	2020-05-31 21:58
To Make the First Decision
Return for Revision	2020-10-04 03:23
Revised	2020-10-14 02:51
Second Decision	2020-10-26 00:11
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-10-26 04:01
Articles in Press	2020-10-26 04:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-10-28 00:34
Publish the Manuscript Online	2020-10-28 10:48

ISSN	2308-3840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic
Manuscript Source	Invited Manuscript
All Author List	Maliha Naseer, Shiva Poola, Francis E Dailey, Hakan Akin and Veysel Tahan
Funding Agency and Grant Number
Corresponding Author	Veysel Tahan, FACG, FACP, FEBG, MD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, 1 Hospital Drive, Columbia, MO 65212, United States. tahanv@health.missouri.edu
Key Words	SARS-CoV-2; COVID-19; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Pandemic
Core Tip	The current pandemic caused by coronavirus disease 2019 (COVID-19) has resulted in devastating consequences worldwide. This viral infection affecting the respiratory and gastrointestinal systems is most severe in patients with co-morbid conditions, including the immunocompromised. Patients with inflammatory bowel disease are often malnourished and on immunosuppressive medications; management of this population poses unique challenges during this time. In this review, we summarize the current evidence and understanding of the management of inflammatory bowel disease during the COVID-19 pandemic. We further outline the current guidelines for treatment of those with inflammatory bowel disease and offer education for measures to prevent infections, including COVID-19.
Publish Date	2020-10-28 10:48
Citation	Naseer M, Poola S, Dailey FE, Akin H, Tahan V. Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic. World J Meta-Anal 2020; 8(5): 383-399
URL	https://www.wjgnet.com/2308-3840/full/v8/i5/383.htm
DOI	https://dx.doi.org/10.13105/wjma.v8.i5.383

Full Article (PDF)	WJMA-8-383.pdf
Full Article (Word)	WJMA-8-383.docx
Manuscript File	57210_Auto_Edited.docx
Answering Reviewers	57210-Answering reviewers.pdf
Audio Core Tip	57210-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	57210-Conflict-of-interest statement.pdf
Copyright License Agreement	57210-Copyright license agreement.pdf
Peer-review Report	57210-Peer-review(s).pdf
Scientific Misconduct Check	57210-Scientific misconduct check.pdf
Scientific Editor Work List	57210-Scientific editor work list.pdf
CrossCheck Report	57210-CrossCheck report.pdf